Loading company…
TSG Therapeutics develops antiviral medicines targeting viral infections.
TSG Therapeutics is a preclinical biopharmaceutical company developing antiviral drug candidates that target viral envelopes and membranes. Its technologies are intended to support broad-spectrum antiviral treatments. Founded in 2016, the company is based in Singapore and works with the US National Institutes of Health, Vanderbilt University and other organizations. CEO Will Wonhyung Park leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in